Characterization of sphere-propagating cells with stem-like properties from DU145 prostate cancer cells

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1813, Issue 5, 2011, Pages 683-694

  Rybak, Adrian P ^a,b,c,d   He, Lizhi ^a,b,c,d   Kapoor, Anil ^b,c,d   Cutz, Jean Claude ^b   Tang, Damu ^a,b,c,d  

^a Division of Nephrology   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c MCMASTER UNIVERSITY   (Canada)

^d ST JOSEPH S HOSPITAL   (Canada)

Author keywords

AKT; PI3K; Prostate cancer stem cell; PTEN

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; CD24 ANTIGEN; CYTOKERATIN; CYTOKERATIN 18; EPIDERMAL GROWTH FACTOR; HERMES ANTIGEN; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B; TUMOR MARKER; VERY LATE ACTIVATION ANTIGEN 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CANCER STEM CELL; CELL ADHESION; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL RENEWAL; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME ACTIVATION; HUMAN; HUMAN CELL; MALE; MONOLAYER CULTURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TUMOR XENOGRAFT;

ANIMALS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SEPARATION; ENZYME ACTIVATION; EPIDERMAL GROWTH FACTOR; EPITHELIAL CELLS; FIBROBLAST GROWTH FACTOR 2; HUMANS; MALE; MICE; MICE, SCID; NEOPLASTIC STEM CELLS; PHOSPHATIDYLINOSITOL 3-KINASES; PROSTATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; SPHEROIDS, CELLULAR; STEM CELL FACTOR; TUMOR MARKERS, BIOLOGICAL; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 79955660106     PISSN: 01674889     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2011.01.018     Document Type: Article

References (51)

1. Jemal A., Siegel R., Ward E., Murray T., Xu J., Thun M.J. Cancer statistics, 2007. CA Cancer J. Clin. 2007, 57:43-66.
2. Williams H., Powell I.J. Epidemiology, pathology, and genetics of prostate cancer among African Americans compared with other ethnicities. Meth. Mol. Biol. 2009, 472:439-453.
3. Ross J.S. The androgen receptor in prostate cancer: therapy target in search of an integrated diagnostic test. Adv. Anat. Pathol. 2007, 14:353-357.
4. Moon C., Park J.C., Chae Y.K., Yun J.H., Kim S. Current status of experimental therapeutics for prostate cancer. Cancer Lett. 2008, 266:116-134.
5. Tang D.G., Patrawala L., Calhoun T., Bhatia B., Choy G., Schneider-Broussard R., Jeter C. Prostate cancer stem/progenitor cells: identification, characterization, and implications. Mol. Carcinog. 2007, 46:1-14.
6. Lawson D.A., Witte O.N. Stem cells in prostate cancer initiation and progression. J. Clin. Invest. 2007, 117:2044-2050.
7. Kasper S. Stem cells: The root of prostate cancer?. J. Cell. Physiol. 2008, 216:332-336.
8. Collins A.T., Berry P.A., Hyde C., Stower M.J., Maitland N.J. Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res. 2005, 65:10946-10951.
9. Singh S.K., Clarke I.D., Terasaki M., Bonn V.E., Hawkins C., Squire J., Dirks P.B. Identification of a cancer stem cell in human brain tumors. Cancer Res. 2003, 63:5821-5828.
10. Singh S.K., Hawkins C., Clarke I.D., Squire J.A., Bayani J., Hide T., Henkelman R.M., Cusimano M.D., Dirks P.B. Identification of human brain tumour initiating cells. Nature 2004, 432:396-401.
11. Al-Hajj M., Wicha M.S., Benito-Hernandez A., Morrison S.J., Clarke M.F. Prospective identification of tumorigenic breast cancer cells. Proc. Natl Acad. Sci. USA 2003, 100:3983-3988.
12. O'Brien C.A., Pollett A., Gallinger S., Dick J.E. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 2007, 445:106-110.
13. Ricci-Vitiani L., Lombardi D.G., Pilozzi E., Biffoni M., Todaro M., Peschle C., De Maria R. Identification and expansion of human colon-cancer-initiating cells. Nature 2007, 445:111-115.
14. Richardson G.D., Robson C.N., Lang S.H., Neal D.E., Maitland N.J., Collins A.T. CD133, a novel marker for human prostatic epithelial stem cells. J. Cell Sci. 2004, 117:3539-3545.
15. Leong K.G., Wang B.E., Johnson L., Gao W.Q. Generation of a prostate from a single adult stem cell. Nature 2008, 456:804-808.
16. Miki J., Furusato B., Li H., Gu Y., Takahashi H., Egawa S., Sesterhenn I.A., McLeod D.G., Srivastava S., Rhim J.S. Identification of putative stem cell markers, CD133 and CXCR4, in hTERT-immortalized primary nonmalignant and malignant tumor- derived human prostate epithelial cell lines and in prostate cancer specimens. Cancer Res. 2007, 67:3153-3161.
17. Gu G., Yuan J., Wills M., Kasper S. Prostate cancer cells with stem cell characteristics reconstitute the original human tumor in vivo. Cancer Res. 2007, 67:4807-4815.
18. Li H., Zhou Test J. article sample title placed here. Exp. Cell Res. 2008, 314:92-102.
19. Patrawala L., Calhoun T., Schneider-Broussard R., Li Test H. article sample title placed here. Oncogene 2006, 25:1696-1708.
20. Dubrovska A., Kim S., Salamone R.J., Walker J.R., Maira S.M., García-Echeverría C., Schultz P.G., Reddy V.A. The role of PTEN/Akt/PI3K signaling in the maintenance and viability of prostate cancer stem-like cell populations. Proc. Natl Acad. Sci. USA 2009, 106:268-273.
21. Li Y., Wu D., Chen B., Ingram A., He L., Liu L., Zhu D., Kapoor A., Tang D. ATM activity contributes to the tumor-suppressing functions of p14ARF. Oncogene 2004, 23:7355-7365.
22. Tang D., Okada H., Ruland J., Liu L., Stambolic V., Mak T.W., Ingram A.J. Akt is activated in response to an apoptotic signal. J. Biol. Chem. 2001, 276:30461-30466.
23. Abate-Shen C., Shen M.M. Molecular genetics of prostate cancer. Genes Dev. 2000, 14:2410-2434.
24. Long R.M., Morrissey C., Fitzpatrick J.M., Watson R.W. Prostate epithelial cell differentiation and its relevance to the understanding of prostate cancer therapies. Clin. Sci. 2005, 108:1-11.
25. Maygarden S.J., Strom S., Ware J.L. Localization of epidermal growth factor receptor by immunohistochemical methods in human prostatic carcinoma, prostatic intraepithelial neoplasia, and benign hyperplasia. Arch. Pathol. Lab. Med. 1992, 116:269-273.
26. Tropepe V., Sibilia M., Ciruna B.G., Rossant J., Wagner E.F., van der Kooy D. Distinct neural stem cells proliferate in response to EGF and FGF in the developing mouse telencephalon. Dev. Biol. 1999, 208:166-188.
27. Morshead C.M., Garcia A.D., Sofroniew M.V., van Der Kooy D. The ablation of glial fibrillary acidic protein-positive cells from the adult central nervous system results in the loss of forebrain neural stem cells but not retinal stem cells. Eur. J. Neurosci. 2003, 18:76-84.
28. Reynolds B.A., Weiss S. Clonal and population analyses demonstrate that an EGF- responsive mammalian embryonic CNS precursor is a stem cell. Dev. Biol. 1996, 175:1-13.
29. Okita K., Nakagawa M., Hyenjong H., Ichisaka T., Yamanaka S. Generation of mouse induced pluripotent stem cells without viral vectors. Science 2008, 322:949-953.
30. Stadtfeld M., Maherali N., Breault D.T., Hochedlinger K. Defining molecular cornerstones during fibroblast to iPS cell reprogramming in mouse. Cell Stem Cell 2008, 2:230-240.
31. Brambrink T., Foreman R., Welstead G.G., Lengner C.J., Wernig M., Suh H., Jaenisch R. Sequential expression of pluripotency markers during direct reprogramming of mouse somatic cells. Cell Stem Cell 2008, 2:151-159.
32. Molofsky A.V., Pardal R., Iwashita T., Park I.K., Clarke M.F., Morrison S.J. Bmi-1 dependence distinguishes neural stem cell self-renewal from progenitor proliferation. Nature 2003, 425:962-967.
33. Molofsky A.V., He S., Bydon M., Morrison S.J., Pardal R. Bmi-1 promotes neural stem cell self-renewal and neural development but not mouse growth and survival by repressing the p16Ink4a and p19Arf senescence pathways. Genes Dev. 2005, 19:1432-1437.
34. Fan C., He L., Kapoor A., Gillis A., Rybak A.P., Cutz J.C., Tang D. Bmi1 promotes prostate tumorigenesis via inhibiting p16(INK4A) and p14(ARF) expression. Biochim. Biophys. Acta 2008, 1782:642-648.
35. Lukasz R.U., Memarzadeh S., Wu H., Witte O.N. Bmi-1 is a crucial regulator of prostate stem cell self-renewal and malignant transformation. Cell Stem Cell 2010, 7:682-693.
36. Marhaba R., Klingbeil P., Nuebel T., Nazarenko I., Buechler M.W., Zoeller M. CD44 and EpCAM: cancer-initiating cell markers. Curr. Mol. Med. 2008, 8:784-804.
37. Florek M., Haase M., Marzesco A.M., Freund D., Ehninger G., Huttner W.B., Corbeil D. Prominin-1/CD133, a neural and hematopoietic stem cell marker, is expressed in adult human differentiated cells and certain types of kidney cancer. Cell Tissue Res. 2005, 319:15-26.
38. Patrawala L., Calhoun-Davis T., Schneider-Broussard R., Tang D.G. Hierarchical organization of prostate cancer cells in xenograft tumors: the CD44+alpha2beta1+ cell population is enriched in tumor-initiating cells. Cancer Res. 2007, 67:6796-6805.
39. Joshua A.M., Evans A., Van der Kwast T., Zielenska M., Meeker A.K., Chinnaiyan A., Squire J.A. Prostatic preneoplasia and beyond. Biochim. Biophys. Acta 2008, 1785:156-181.
40. Marian C.O., Shay J.W. Prostate tumor-initiating cells: a new target for telomerase inhibition therapy?. Biochim. Biophys. Acta 2009, 1792:289-296.
41. Maitland N.J., Bryce S.D., Stower M.J., Collins A.T. Prostate cancer stem cells: a target for new therapies. Ernst Schering Found. Symp. Proc. 2006, 5:155-179.
42. Teglund S., Toftgård R. Hedgehog beyond medulloblastoma and basal cell carcinoma. Biochim. Biophys. Acta 2010, 1805:181-208.
43. Pfeiffer M.J., Schalken J.A. Stem Cell Characteristics in Prostate Cancer Cell Lines. Eur. Urol. 2010, 57:246-254.
44. Bidlingmaier S., Zhu X., Liu B. The utility and limitations of glycosylated human CD133 epitopes in defining cancer stem cells. J. Mol. Med. 2008, 86:1025-1032.
45. Mizrak D., Brittan M., Alison M.R. CD133: molecule of the moment. J. Pathol. 2008, 214:3-9.
46. Kemper K., Sprick M.R., de Bree M., Scopelliti A., Vermeulen L., Hoek M., Zeilstra J., Pals S.T., Mehmet H., Stassi G., Medema J.P. The AC133 epitope, but not the CD133 protein, is lost upon cancer stem cell differentiation. Cancer Res. 2010, 70:719-729.
47. Green C.L., Loken M., Buck D., Deeg H.J. Discordant expression of AC133 and AC141 in patients with myelodysplastic syndrome. Leukemia 2000, 14:770-772.
48. Chi S.G., deVere White R.W., Muenzer J.T., Gumerlock P.H. Frequent alteration of CDKN2 (p16(INK4A)/MTS1) expression in human primary prostate carcinomas. Clin. Cancer Res. 1997, 3:1889-1897.
49. Morrison S.J., Spradling A.C. Stem cells and niches: mechanisms that promote stem cell maintenance throughout life. Cell 2008, 132:598-611.
50. Gao M.Q., Choi Y.P., Kang S., Youn J.H., Cho N.H. CD24(+) cells from hierarchically organized ovarian cancer are enriched in cancer stem cells. Oncogene 2010, 29:2672-2680.
51. Wei C., Guomin W., Yujun L., Ruizhe Q. Cancer stem-like cells in human prostate carcinoma cells DU145: the seeds of the cell line?. Cancer Biol Ther. 2007, 6:763-768.